Abstract Preview

This document specifies test methodologies for the evaluation of the electromagnetic compatibility (EMC) of active implantable cardiovascular devices that provide one or more therapies for bradycardia, tachycardia and cardiac resynchronization in conjunction with transvenous lead systems.

NOTE This document was designed for pulse generators used with endocardial leads or epicardial leads. At the time of this edition, the authors recognized the emergence of technologies that do not use endocardial leads or epicardial leads for which adaptations of this part will be required. Such adaptations are left to the discretion of manufacturers incorporating these technologies.

It specifies performance limits of these devices, which are subject to interactions with EM emitters operating across the EM spectrum in the two following ranges:

— 0 Hz ≤ ? < 385 MHz;

— 385 MHz ≤ ? ≤ 3 000 MHz

This document also specifies requirements for the protection of these devices from EM fields encountered in a therapeutic environment and defines their required accompanying documentation, providing manufacturers of EM emitters with information about their expected level of immunity.


General information

  • Status :  Published
    Publication date : 2019-09
  • Edition : 2
    Number of pages : 134
  • :
    ISO/TC 150/SC 6
    Active implants
  • 11.040.40
    Implants for surgery, prosthetics and orthotics
    33.100.01
    Electromagnetic compatibility in general

Buy this standard

Format Language
PDF + ePub
Paper
  • CHF198

Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)

Keep up to date with ISO

Sign up to our newsletter for the latest news, views and product information